
Susan L. Whiteway
Pediatric Hematology Oncology
111 Michigan Avenue Northwest
Washington, DC 20010
Washington, DC 20010
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Expanding the Treatment Window for the FDA-Approved Radiation Countermeasure Nplate.
Journal: Military medicine
Published: August 06, 2026
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee.
Journal: Pediatric blood & cancer
Published: February 11, 2025
Innovative Algorithm for Incidence of Leukemia and Lymphoma in the U.S. Military Health Care System.
Innovative Algorithm for Incidence of Leukemia and Lymphoma in the U.S. Military Health Care System.
Journal: Military medicine
Published: December 11, 2024
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 20, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group.
Journal: Journal of adolescent and young adult oncology
Published: February 01, 2023
Treatment Refractory Soft Tissue Myoepithelial Carcinoma With an ARID1A Mutation.
Journal: Journal of pediatric hematology/oncology
Published: November 05, 2022
Healthcare providers' promotion of physical activity among child and adolescent cancer survivors: strategies and challenges.
Journal: Journal of cancer survivorship : research and practice
Published: February 01, 2022
Malignant Giant Cell Tumor of Bone With a KRAS G12V Mutation.
Journal: Journal of pediatric hematology/oncology
Published: October 20, 2020
Pediatric Myelodysplastic Syndrome With Germline RRAS Mutation: Expanding the Phenotype of RASopathies.
Journal: Journal of pediatric hematology/oncology
Published: January 19, 2020
Oncogenic GOPC-ROS1 Fusion Identified in a Congenital Glioblastoma Case.
Journal: Journal of pediatric hematology/oncology
Published: January 14, 2020
Dysfunctional Immune System Reconstitution After Rituximab Exposure In Utero.
Journal: Journal of pediatric hematology/oncology
Published: December 13, 2019
Targetable molecular alterations in congenital glioblastoma.
Journal: Journal of neuro-oncology
Published: October 29, 2019
Last Updated: 09/26/2026